Abstract:BACKGROUND:There has been paid more and more attention to supervised classification models in the area of predicting drug-target interactions (DTIs). However, in terms of classification, unavoidable missing DTIs in data would cause three issues which have not yet been addressed appropriately by former approaches. Directly labeled as negatives (non-DTIs), missing DTIs increase the confusion of positives (DTIs) and negatives, aggravate the imbalance between few positives and many negatives, and are usually discriminated as highly-scored false positives, which influence the existing measures sharply.RESULTS:Under the framework of local classification model (LCM), this work focuses on the scenario of predicting how possibly a new drug interacts with known targets. To address the first two issues, two strategies, Spy and Super-target, are introduced accordingly and further integrated to form a two-layer LCM. In the bottom layer, Spy-based local classifiers for protein targets are built by positives, as well as reliable negatives identified among unlabeled drug-target pairs. In the top layer, regular local classifiers specific to super-targets are built with more positives generated by grouping similar targets and their interactions. Furthermore, to handle the third issue, an additional performance measure, Coverage, is presented for assessing DTI prediction. The experiments based on benchmark datasets are finally performed under five-fold cross validation of drugs to evaluate this approach. The main findings are concluded as follows. (1) Both two individual strategies and their combination are effective to missing DTIs, and the combination wins the best. (2) Having the advantages of less confusing decision boundary at the bottom layer and less biased decision boundary at the top layer, our two-layer LCM outperforms two former approaches. (3) Coverage is more robust to missing interactions than other measures and is able to evaluate how far one needs to go down the list of targets to cover all the proper targets of a drug.CONCLUSIONS:Proposing two strategies and one performance measure, this work has addressed the issues derived from missing interactions, which cause confusing and biased decision boundaries in classifiers, as well as the inappropriate measure of predicting performance, in the scenario of predicting interactions between new drugs and known targets.

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Prediction of Drug-Target Interactions by Ensemble Learning Method from Protein Sequence and Drug Fingerprint

Drug-Target Interaction Prediction Based On Drug Fingerprint Information And Protein Sequence

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

A Systematic Prediction of Drug-Target Interactions Using Molecular Fingerprints and Protein Sequences

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Prediction of Drug–Target Interactions by Combining Dual-Tree Complex Wavelet Transform with Ensemble Learning Method

A Sparse Feature Extraction Method with Elastic Net for Drug-Target Interaction Identification.

Predicting Existing Targets for New Drugs Base on Strategies for Missing Interactions

Ensemble Learning Prediction of Drug-Target Interactions Using GIST Descriptor Extracted from PSSM-Based Evolutionary Information.

RFDT: A Rotation Forest-based Predictor for Predicting Drug-Target Interactions Using Drug Structure and Protein Sequence Information

Predicting Drug–Target Interactions Based on the Ensemble Models of Multiple Feature Pairs

Incorporating Chemical Sub-Structures and Protein Evolutionary Information for Inferring Drug-Target Interactions

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

RFDTI: Using Rotation Forest with Feature Weighted for Drug-Target Interaction Prediction from Drug Molecular Structure and Protein Sequence

DTIRF: Predicting Drug-Target Interactions Based on Improved Rotation Forest from Drug Molecular Structure and Protein Sequence

Identification of Drug-Target Interactions Via Multiple Information Integration.